- Home
- SGMO vs RBKB Comparison
SGMO vs RBKB Comparison
Compare SGMO & RBKB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SGMO
- RBKB
- Stock Information
- Founded
- SGMO 1995
- RBKB 1860
- Country
- SGMO United States
- RBKB United States
- Employees
- SGMO N/A
- RBKB N/A
- Industry
- SGMO Biotechnology: Biological Products (No Diagnostic Substances)
- RBKB Banks
- Sector
- SGMO Health Care
- RBKB Finance
- Exchange
- SGMO Nasdaq
- RBKB Nasdaq
- Market Cap
- SGMO 122.8M
- RBKB 111.3M
- IPO Year
- SGMO 2000
- RBKB 2019
- Fundamental
- Price
- SGMO $0.54
- RBKB $12.69
- Analyst Decision
- SGMO Buy
- RBKB
- Analyst Count
- SGMO 6
- RBKB 0
- Target Price
- SGMO $4.50
- RBKB N/A
- AVG Volume (30 Days)
- SGMO 5.7M
- RBKB 11.7K
- Earning Date
- SGMO 08-12-2025
- RBKB 07-24-2025
- Dividend Yield
- SGMO N/A
- RBKB N/A
- EPS Growth
- SGMO N/A
- RBKB N/A
- EPS
- SGMO N/A
- RBKB N/A
- Revenue
- SGMO $63,756,000.00
- RBKB $31,018,000.00
- Revenue This Year
- SGMO $1.29
- RBKB N/A
- Revenue Next Year
- SGMO $1.60
- RBKB N/A
- P/E Ratio
- SGMO N/A
- RBKB N/A
- Revenue Growth
- SGMO 239.92
- RBKB N/A
- 52 Week Low
- SGMO $0.41
- RBKB $7.30
- 52 Week High
- SGMO $3.18
- RBKB $13.06
- Technical
- Relative Strength Index (RSI)
- SGMO 50.80
- RBKB 58.00
- Support Level
- SGMO $0.50
- RBKB $12.69
- Resistance Level
- SGMO $0.70
- RBKB $12.64
- Average True Range (ATR)
- SGMO 0.05
- RBKB 0.32
- MACD
- SGMO 0.01
- RBKB 0.02
- Stochastic Oscillator
- SGMO 29.17
- RBKB 73.76
About SGMO Sangamo Therapeutics Inc.
Sangamo Therapeutics Inc is a genomic medicine company committed to translating ground-breaking science into medicines that transform the lives of patients and families afflicted with serious neurological diseases. Its pipeline products include the Priority Neurology Pipeline offers Chronic Neuropathic Pain, Prion Disease, and Neurology; Partnered Programs offer Hemophilia A, Oncology, ALS/FTD, and Huntington's Disease; and Other Pipelines include Fabry Disease, Renal Transplant, Inflammatory Bowel Disease, and Multiple Sclerosis.
About RBKB Rhinebeck Bancorp Inc.
Rhinebeck Bancorp Inc is the holding company for Rhinebeck Bank which provides a full range of banking and financial services to consumer and commercial customers. Financial services, including investment advisory and financial product sales, are offered through a division of the Bank doing business as Rhinebeck Asset Management (RAM). The Bank's primary business activity is accepting deposits from the general public and using those funds to originate indirect automobile loans (automobile loans referred by automobile dealerships), commercial real estate loans (which include multi-family real estate loans and commercial construction loans), commercial business loans and one- to four-family residential real estate loans, and to purchase investment securities.